Published in Pregnancy Hypertens on June 06, 2013
[In Process Citation]. Tidsskr Nor Laegeforen (2016) 4.40
Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density. Am J Hum Genet (2003) 2.86
Breech birth at term: vaginal delivery or elective cesarean section? A systematic review of the literature by a Norwegian review team. Acta Obstet Gynecol Scand (2004) 2.05
Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry. J Clin Endocrinol Metab (2009) 2.01
Effect of a cholesterol-lowering diet on maternal, cord, and neonatal lipids, and pregnancy outcome: a randomized clinical trial. Am J Obstet Gynecol (2005) 2.01
Prognostic value of osteoprotegerin in heart failure after acute myocardial infarction. J Am Coll Cardiol (2004) 1.88
Are nonresorbing osteoclasts sources of bone anabolic activity? J Bone Miner Res (2007) 1.82
Preoperative octreotide treatment in newly diagnosed acromegalic patients with macroadenomas increases cure short-term postoperative rates: a prospective, randomized trial. J Clin Endocrinol Metab (2008) 1.79
Physical activity and the risk of preeclampsia: a systematic review and meta-analysis. Epidemiology (2014) 1.74
Complications of cesarean deliveries: rates and risk factors. Am J Obstet Gynecol (2004) 1.72
Parathyroid hormone, but not vitamin D, is associated with the metabolic syndrome in morbidly obese women and men: a cross-sectional study. Cardiovasc Diabetol (2009) 1.62
Absence of enhanced systemic inflammatory response at 18 weeks of gestation in women with subsequent pre-eclampsia. BJOG (2002) 1.61
Dietary supplementation with L-arginine or placebo in women with pre-eclampsia. Acta Obstet Gynecol Scand (2004) 1.51
[A pregnant woman with abdominal pain and fever]. Tidsskr Nor Laegeforen (2007) 1.49
Effect of a cholesterol-lowering diet during pregnancy on maternal and fetal Doppler velocimetry: the CARRDIP study. Am J Obstet Gynecol (2007) 1.49
Patients with high bone mass phenotype exhibit enhanced osteoblast differentiation and inhibition of adipogenesis of human mesenchymal stem cells. J Bone Miner Res (2007) 1.48
Gene expression profiling identifies ESRP1 as a potential regulator of epithelial mesenchymal transition in somatotroph adenomas from a large cohort of patients with acromegaly. J Clin Endocrinol Metab (2012) 1.44
Intra-operative MRI facilitates tumour resection during trans-sphenoidal surgery for pituitary adenomas. Acta Neurochir (Wien) (2011) 1.43
[A 33-year old pregnant woman with nausea, itching and fatigue]. Tidsskr Nor Laegeforen (2007) 1.39
Cesarean sections and fetal death rates. Acta Obstet Gynecol Scand (2014) 1.38
[Postpartum dyspnea, edema and fever]. Tidsskr Nor Laegeforen (2005) 1.38
A screening and intervention program aimed to reduce mortality and serious morbidity associated with severe neonatal alloimmune thrombocytopenia. Blood (2007) 1.33
Characterization of osteoclasts from patients harboring a G215R mutation in ClC-7 causing autosomal dominant osteopetrosis type II. Am J Pathol (2004) 1.31
Indications for cesarean deliveries in Norway. Am J Obstet Gynecol (2003) 1.31
Physical activity level and weight gain in a cohort of pregnant Norwegian women. Acta Obstet Gynecol Scand (2007) 1.31
Acidification of the osteoclastic resorption compartment provides insight into the coupling of bone formation to bone resorption. Am J Pathol (2005) 1.26
Glucocorticoid replacement therapy and pharmacogenetics in Addison's disease: effects on bone. Eur J Endocrinol (2009) 1.19
Autoimmune polyendocrine syndrome type 1 in Norway: phenotypic variation, autoantibodies, and novel mutations in the autoimmune regulator gene. J Clin Endocrinol Metab (2006) 1.19
Localization of the gene causing autosomal dominant osteopetrosis type I to chromosome 11q12-13. J Bone Miner Res (2002) 1.14
Inflammatory mediators in morbidly obese subjects: associations with glucose abnormalities and changes after oral glucose. Eur J Endocrinol (2009) 1.13
Medical management of primary hyperparathyroidism: proceedings of the fourth International Workshop on the Management of Asymptomatic Primary Hyperparathyroidism. J Clin Endocrinol Metab (2014) 1.09
Categorisation of continuous exposure variables revisited. A response to the Hyperglycaemia and Adverse Pregnancy Outcome (HAPO) Study. BMC Med Res Methodol (2010) 1.08
Levels of serotonin, sclerostin, bone turnover markers as well as bone density and microarchitecture in patients with high-bone-mass phenotype due to a mutation in Lrp5. J Bone Miner Res (2011) 1.06
Modifiable determinants of fetal macrosomia: role of lifestyle-related factors. Acta Obstet Gynecol Scand (2008) 1.06
Fetal growth versus birthweight: the role of placenta versus other determinants. PLoS One (2012) 1.03
Newborn body fat: associations with maternal metabolic state and placental size. PLoS One (2013) 1.00
Adiposity-related inflammation: effects of pregnancy. Obesity (Silver Spring) (2013) 0.99
The impact of advanced maternal age and parity on obstetric and perinatal outcomes in singleton gestations. Arch Gynecol Obstet (2010) 0.98
Normal overall mortality rate in Addison's disease, but young patients are at risk of premature death. Eur J Endocrinol (2008) 0.98
Effect of hyperglycemic condition on proteoglycan secretion in cultured human endothelial cells. Eur J Nutr (2006) 0.96
Early posttransplant serum osteoprotegerin levels predict long-term (8-year) patient survival and cardiovascular death in renal transplant patients. J Am Soc Nephrol (2006) 0.95
Serum carotenoids and fat-soluble vitamins in women with type 1 diabetes and preeclampsia: a longitudinal study. Diabetes Care (2011) 0.95
Pregnancy complications by overweight and residential area. A prospective study of an urban Norwegian cohort. Acta Obstet Gynecol Scand (2006) 0.95
Restoration of the coupling process and normalization of bone mass following successful treatment of endogenous Cushing's syndrome: a prospective, long-term study. Eur J Endocrinol (2006) 0.95
Long-term parental psychological distress among parents of children with a malformation--a prospective longitudinal study. Am J Med Genet A (2010) 0.95
STUB1 mutations in autosomal recessive ataxias - evidence for mutation-specific clinical heterogeneity. Orphanet J Rare Dis (2014) 0.94
Physical activity and calcium consumption are important determinants of lower limb bone mass in older women. J Bone Miner Res (2004) 0.94
Maternal folate and cobalamin status predicts vitamin status in newborns and 6-month-old infants. J Nutr (2010) 0.93
Adenoma granulation pattern correlates with clinical variables and effect of somatostatin analogue treatment in a large series of patients with acromegaly. Clin Endocrinol (Oxf) (2012) 0.93
Eclampsia in Scandinavia: incidence, substandard care, and potentially preventable cases. Acta Obstet Gynecol Scand (2006) 0.93
Increased risk of macrosomia among overweight women with high gestational rise in fasting glucose. J Matern Fetal Neonatal Med (2010) 0.92
Shape information from glucose curves: functional data analysis compared with traditional summary measures. BMC Med Res Methodol (2013) 0.91
Congenital anomalies in newborns of women with type 1 diabetes: nationwide population-based study in Norway, 1999-2004. Acta Obstet Gynecol Scand (2010) 0.91
Fetal liver blood flow distribution: role in human developmental strategy to prioritize fat deposition versus brain development. PLoS One (2012) 0.90
Birth complications, overweight, and physical inactivity. Acta Obstet Gynecol Scand (2009) 0.89
Why do pregnant women stop exercising in the third trimester? Acta Obstet Gynecol Scand (2009) 0.88
Seasonal variation in maternal and umbilical cord 25(OH) vitamin D and their associations with neonatal adiposity. Eur J Endocrinol (2014) 0.88
Understanding coupling between bone resorption and formation: are reversal cells the missing link? Am J Pathol (2013) 0.88
Body composition, endocrine and metabolic profiles in adults with Prader-Willi syndrome. Growth Horm IGF Res (2010) 0.88
One year of growth hormone treatment in adults with Prader-Willi syndrome improves body composition: results from a randomized, placebo-controlled study. J Clin Endocrinol Metab (2010) 0.88
The clinical response to somatostatin analogues in acromegaly correlates to the somatostatin receptor subtype 2a protein expression of the adenoma. Clin Endocrinol (Oxf) (2007) 0.87
Premature loss of bone remodeling compartment canopies is associated with deficient bone formation: a study of healthy individuals and patients with Cushing's syndrome. J Bone Miner Res (2012) 0.87
Determinants of short-term changes in body composition following renal transplantation. Scand J Urol Nephrol (2009) 0.86
Assessing body composition in healthy newborn infants: reliability of dual-energy x-ray absorptiometry. J Clin Densitom (2010) 0.86
Degradation of the organic phase of bone by osteoclasts: a secondary role for lysosomal acidification. J Bone Miner Res (2005) 0.86
Growth hormone treatment in adults with Prader-Willi syndrome: the Scandinavian study. Endocrine (2011) 0.86
Vaginal breech delivery: results of a prospective registration study. BMC Pregnancy Childbirth (2013) 0.85
High glucose and Nepsilon-(carboxymethyl) lysine bovine serum albumin modulate release of matrix metalloproteinases in cultured human endothelial cells. Eur J Nutr (2006) 0.85
Expression of SSTR2a, but not of SSTRs 1, 3, or 5 in somatotroph adenomas assessed by monoclonal antibodies was reduced by octreotide and correlated with the acute and long-term effects of octreotide. J Clin Endocrinol Metab (2013) 0.84
Study protocol: fit for delivery - can a lifestyle intervention in pregnancy result in measurable health benefits for mothers and newborns? A randomized controlled trial. BMC Public Health (2013) 0.84
Effect of surgery on cardiac structure and function in mild primary hyperparathyroidism. Clin Endocrinol (Oxf) (2011) 0.83
Variations in fetal phenotype in Prader-Willi syndrome. Prenat Diagn (2009) 0.83
Growth hormone treatment for two years is safe and effective in adults with Prader-Willi syndrome. Growth Horm IGF Res (2011) 0.83
Intensity of pituitary adenoma on T2-weighted magnetic resonance imaging predicts the response to octreotide treatment in newly diagnosed acromegaly. Clin Endocrinol (Oxf) (2012) 0.83
Associations between body composition, circulating interleukin-1 receptor antagonist, osteocalcin, and insulin metabolism in active acromegaly. J Clin Endocrinol Metab (2009) 0.82
The expression of E-cadherin in somatotroph pituitary adenomas is related to tumor size, invasiveness, and somatostatin analog response. J Clin Endocrinol Metab (2010) 0.82
Anthropometric characteristics and type 2 diabetes in extremely obese Caucasian subjects: a cross-sectional study. Diabetes Res Clin Pract (2009) 0.82
Reduced bone mass and increased bone turnover in postmenopausal women with epilepsy using antiepileptic drug monotherapy. Scand J Clin Lab Invest (2008) 0.82
Adipocytes as a source of increased circulating levels of nicotinamide phosphoribosyltransferase/visfatin in active acromegaly. J Clin Endocrinol Metab (2012) 0.82
Characterization of acid flux in osteoclasts from patients harboring a G215R mutation in ClC-7. Biochem Biophys Res Commun (2008) 0.82
Medicines and bone loss. J Clin Endocrinol Metab (2013) 0.82
Effects of parathyroidectomy versus observation on the development of vertebral fractures in mild primary hyperparathyroidism. J Clin Endocrinol Metab (2015) 0.81
Surgical complications after transsphenoidal microscopic and endoscopic surgery for pituitary adenoma: a consecutive series of 506 procedures. Acta Neurochir (Wien) (2013) 0.81
Six-month preoperative octreotide treatment in unselected, de novo patients with acromegaly: effect on biochemistry, tumour volume, and postoperative cure. Clin Endocrinol (Oxf) (2011) 0.81
Association between aerobic fitness in late pregnancy and duration of labor in nulliparous women. Acta Obstet Gynecol Scand (2009) 0.81
Umbilical cord levels of sclerostin, placental weight, and birth weight are predictors of total bone mineral content in neonates. Eur J Endocrinol (2013) 0.81